Cadence’s high-quality remote patient monitoring program shows significant improvement in blood glucose control
In a study of 183 type 2 diabetes patients enrolled in Cadence’s program, 43% achieved their blood glucose goal.
Cadence released new data highlighting the positive impact of high-quality remote patient monitoring (RPM) on health outcomes in type 2 diabetes patients. In a study of 183 patients, results showed that 43% of patients enrolled in Cadence’s program successfully achieved their blood glucose target.
Presented in a poster presentation at the American College of Cardiology’s 2024 conference, the analysis showed how a virtual diabetes program that leverages high-quality remote patient monitoring can promote the necessary patient engagement to achieve significant improvement in blood glucose control at scale.
“We’re excited about this early data showing the effect of a high-quality remote care program for patients with diabetes,” shared David Feldman, Medical Advisor to Cadence and first author on the diabetes abstract. “By combining patient-friendly, smart monitoring devices with an expert clinical team who provide proactive lifestyle and medication treatment recommendations, we are able to make meaningful improvements in diabetes care. We look forward to continuing our progress as we scale this program nationwide, guiding patients to improved diabetes control.”
Diabetes control was achieved through Cadence’s comprehensive diabetes program which leverages regular virtual visits with a nurse-practitioner led team of clinicians and care navigators, and technology-enabled diabetes treatment protocols. Vitals were received using smart glucometers taken by the patient at home to measure their blood glucose levels.
Read the full abstract in the Journal of the American College of Cardiology here:
https://www.jacc.org/doi/10.1016/S0735-1097%2824%2904439-5
